| Intention‐to‐treat | This will comprise all randomized patients (except those randomized in error) |
| This population will be evaluated for all endpoints | |
| Per‐protocol | This is a subset of the intention‐to‐treat population encompassing correctly included patients who have received prostacyclin or placebo according to the protocol (i.e., 72‐h infusion of prostacyclin or placebo after inclusion or until dead or discharged to ward, whichever comes first). This population will be evaluated for the primary endpoint only |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.